CAS9 Technology Market, Global Outlook and Forecast 2023-2030
CAS9 Technology Market, Global Outlook and Forecast 2023-2030
This report contains market size and forecasts of CAS9 Technology in Global, including the following market information:
Global CAS9 Technology Market Size 2024-2030, ($ millions)
The global CAS9 Technology market is projected to reach US$ million by 2029.
We surveyed the CAS9 Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CAS9 Technology Market, by Type, 2024-2030 ($ millions)
Global CAS9 Technology Market Segment Percentages, by Type
Genome Engineering
Disease Models
Global CAS9 Technology Market, by Application, 2024-2030 ($ millions)
Global CAS9 Technology Market Segment Percentages, by Application
Biotechnology & Pharmaceutical Companies
Academic & Research Institutes
Global CAS9 Technology Market, By Region and Country, 2024-2030 ($ Millions)
Global CAS9 Technology Market Segment Percentages, by region and country
United States
Europe
Asia
China
Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Cellecta Inc.
abm Inc.
GenScript
CRISPR Therapeutic
Intellia Therapeutics Inc.
GE Healthcare
Takara Bio Inc.
AstraZeneca
PLC
Merck KGaA
Bio-Rad Laboratories Inc.
Danaher Corporation (Integrated DNA Technologies Inc.)
New England Biolabs
OriGene Technologies Inc.
Lonza Group
Thermo Fisher Scientific
